Industry / France
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Sanofi Pasteur To Acquire UK's Acambis
July 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
The board of UK vaccine specialist Acambis has unanimously recommended a GBP276mn (US$547mn) takeover bid from French firm Sanofi Pasteur, the vaccines arm of French pharmaceutical giant Sanofi-Aventis. The offer - a premium of 65.2% on Acambasis' share price at the time of the offer - will see another small firm lose its independence, as consolidation continues dominate industry